ICD-10-PCS Billable Code

D90B0ZZ

Beam Radiation Larynx to None with None, Photons <1 MeV Approach

Procedural Specifications

Clinical Axis Detail Definition
SectionD Radiation Therapy
Body System9 Ear, Nose, Mouth and Throat
Operation0 Beam Radiation
Body PartB Larynx
Approach0 Photons <1 MeV
DeviceZ None
QualifierZ None

Procedure Overview

Beam radiation to the ear, nose, mouth, and throat uses an external source to direct high-energy rays at tumors or abnormal tissue in structures such as the nasopharynx, oral cavity, larynx, or salivary glands. It is a cornerstone treatment for many head and neck cancers, either as the primary therapy or combined with surgery and chemotherapy, and works by damaging the DNA of rapidly dividing cancer cells so they can no longer grow.

Because this region contains numerous structures involved in speech, swallowing, and hearing, treatment is usually planned with detailed imaging to shape the radiation field as tightly as possible around the target. Patients typically receive a course of daily treatments over several weeks, and side effects like dry mouth, sore throat, or skin irritation in the treated area are managed alongside the therapy.

Anatomy & Axis Detail

Larynx

The larynx houses the vocal cords and airway protective structures, and its central role in voice production and airway patency makes beam radiation an attractive organ-preserving alternative to surgery for many laryngeal cancers. Treatment planning must account for the larynx's cartilaginous framework, which can be affected by radiation-induced edema or, less commonly, cartilage necrosis, and for its constant motion during swallowing and breathing, which requires immobilization strategies and sometimes respiratory gating. The proximity of the larynx to the thyroid gland, esophagus, and major vessels of the neck means fields must be shaped to limit dose to these adjacent structures. Because early-stage glottic disease is often confined to the vocal cords while more advanced disease may involve the supraglottic or subglottic larynx, the specific extent of laryngeal involvement shapes both technique and documentation.

Modality Qualifier: Photons <1 MeV

Photons less than 1 MeV specifies that external beam radiation therapy was delivered using low-energy photon beams, a range historically associated with superficial or orthovoltage therapy units treating skin or shallow lesions. This value distinguishes the treatment from the higher-energy photon range used for deeper-seated tumors, reflecting a difference in beam penetration and the depth of tissue the treatment is intended to reach.

Coding & Documentation

A code from this family requires documentation confirming an external beam source directed at a specific ENT structure, along with the modality (such as photons or electrons) and the qualifier describing the type of radiation used. The treatment planning note and daily treatment records from radiation oncology are the primary sources coders rely on to confirm body part and technique.

Commonly Confused With

BrachytherapyThis is frequently mixed up with Brachytherapy to the same region, since both treat similar cancers; the difference is that beam radiation originates from a machine outside the body, while brachytherapy places a radioactive source inside or against the tissue.
Stereotactic RadiosurgeryIt can also be confused with Stereotactic Radiosurgery, which is distinguished by its use of highly focused, image-guided targeting typically delivered in one or a few sessions rather than a standard fractionated course.